Perrigo Company plc
NYSE:PRGO · New York Stock Exchange
-$0.20 today
Vol 5.13M · Avg 2.96M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-57.92%
Period High
$26.18
Period Low
$9.02
Latest
$10.25
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.54B
Amicus Therapeutics, Inc.
FOLD
$4.55B
LivaNova PLC
NASDAQ:LIVN
$4.36B
Heartflow, Inc. Common Stock
NASDAQ:HTFL
$2.86B
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
$2.71B
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
$2.56B
Surgery Partners, Inc.
NASDAQ:SGRY
$1.87B
HUTCHMED (China) Limited
NASDAQ:HCM
$1.79B
Bausch Health Companies Inc.
NYSE:BHC
$1.75B
Alphatec Holdings, Inc.
NASDAQ:ATEC
$1.32B
What is the latest PRGO filing?
The latest filing shown is 4 dated Jun 16, 2026.
How many recent filings does PRGO have?
Intrinsic Alpha currently shows 20 recent filings for PRGO.
Explore More
Continue the stock analysis
Jump to another research area for this company.